ArticleJournal of clinical laboratory analysis2026
Anti-Erythrocyte Antibody Formation in Individuals With and Without Known Sensitisation Pathways Reflecting Indications for Extended Immunohaematology Screening.
Article in Journal of clinical laboratory analysis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBlood transfusion therapies are of vital importance for many patient groups. They can lead to various complications, with the production of anti-erythrocyte antibodies (RBC Ab) being of particular importance. To ascertain which group of participants requires greater protection against RBC Abs, we conducted a study on the antibody incidence in part of Bosnia and Herzegovina-Republika Srpska.
methodsWe investigated the yearly incidence of the identified RBC Abs from 2016 until the end of 2022. The identification of RBC Abs was performed using the gel method on various platforms with commercial immunohaematological panels. For statistical analysis, Python 3.12 was used. The groups were formed based on the likely form of the RBC Ab development.
resultsIn 1106 participants, a total of 1297 antibodies were detected. All groups of patients showed significance that corresponded to the statistical hypothesis set beforehand, which indicated the influence of additional undefined parameters. In the third group, containing participants with no known history of an immunisation pathway, a significant result was observed for anti-K (p = 1.344 × 10^-6), which was completely unexpected.
conclusionAll study groups indicated that it would be advantageous to implement the additional analyses to their routine testing. Further research is needed to identify and prepare prevention strategies for all patient groups from this study.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.